Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “High-grade Ta/ T1 Papillary Disease Bladder Cancer”
Phase 3 1
- Cretostimogene grenadenorepvecCG Oncology, Inc.High-grade Ta/ T1 Papillary Disease Bladder Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.